EFG Asset Management Americas Corp. purchased a new stake in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) during the second quarter, HoldingsChannel.com reports. The fund purchased 26,601 shares of the company’s stock, valued at approximately $1,632,000.
A number of other hedge funds also recently bought and sold shares of the company. Hantz Financial Services Inc. lifted its stake in shares of Doximity by 148.9% in the 2nd quarter. Hantz Financial Services Inc. now owns 453 shares of the company’s stock worth $28,000 after purchasing an additional 271 shares during the period. National Bank of Canada FI bought a new position in Doximity in the first quarter worth approximately $33,000. Brooklyn Investment Group raised its position in Doximity by 70.7% in the first quarter. Brooklyn Investment Group now owns 746 shares of the company’s stock worth $43,000 after acquiring an additional 309 shares during the period. Smartleaf Asset Management LLC boosted its stake in shares of Doximity by 176.0% during the 1st quarter. Smartleaf Asset Management LLC now owns 781 shares of the company’s stock worth $46,000 after acquiring an additional 498 shares during the last quarter. Finally, Cullen Frost Bankers Inc. grew its position in shares of Doximity by 29.7% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 1,427 shares of the company’s stock valued at $88,000 after acquiring an additional 327 shares during the period. Hedge funds and other institutional investors own 87.19% of the company’s stock.
Analysts Set New Price Targets
Several research firms recently weighed in on DOCS. KeyCorp lifted their target price on Doximity from $75.00 to $80.00 and gave the company an “overweight” rating in a research report on Wednesday, October 8th. Zacks Research lowered shares of Doximity from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. BMO Capital Markets assumed coverage on shares of Doximity in a research report on Thursday, November 13th. They issued a “market perform” rating and a $55.00 price target for the company. Wells Fargo & Company upped their target price on shares of Doximity from $55.00 to $62.00 and gave the stock an “equal weight” rating in a report on Monday, August 4th. Finally, Piper Sandler raised their price target on Doximity from $65.00 to $69.00 and gave the company an “overweight” rating in a report on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $68.78.
Insider Activity at Doximity
In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction on Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total transaction of $1,500,000.00. Following the completion of the transaction, the director owned 3,221 shares in the company, valued at $241,575. This trade represents a 86.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Regina M. Benjamin sold 5,000 shares of the stock in a transaction dated Friday, October 10th. The shares were sold at an average price of $70.84, for a total transaction of $354,200.00. Following the completion of the transaction, the director directly owned 19,839 shares of the company’s stock, valued at approximately $1,405,394.76. The trade was a 20.13% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 32,000 shares of company stock valued at $2,339,580 over the last 90 days. 31.30% of the stock is owned by corporate insiders.
Doximity Trading Up 1.1%
Shares of Doximity stock opened at $47.95 on Thursday. The firm has a market cap of $9.03 billion, a PE ratio of 47.95, a PEG ratio of 4.10 and a beta of 1.36. The stock has a 50 day moving average of $66.26 and a 200 day moving average of $62.28. Doximity, Inc. has a 12 month low of $46.38 and a 12 month high of $85.21.
Doximity (NASDAQ:DOCS – Get Free Report) last released its quarterly earnings data on Thursday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The company’s quarterly revenue was up 23.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.30 EPS. Doximity has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. As a group, equities research analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.
Doximity Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Articles
- Five stocks we like better than Doximity
- Most active stocks: Dollar volume vs share volume
- Applied Materials: Up 40% in 2025 With Room to Run Long-Term
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- onsemi Places a $6 Billion Bet on Its Own Stock
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
